Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
7 Dow Stocks With Superior Fundamentals
02:55pm, Tuesday, 06'th Sep 2022
Today I'm writing about Dow stocks to buy. Seasoned investors are realizing that many of the 30 members of the Dow Jones Industrial Average (DJIA) are now trading at low valuation levels and prices.
Take the Zacks Approach to Beat the Market: Walmart (WMT), Ulta Beauty (ULTA), UniCredit (UNCFF) in Focus
10:52am, Tuesday, 06'th Sep 2022 Zacks Investment Research
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our accomplishments from last week.
Best Dividend Stocks To Invest In Right Now? 4 For Your List
02:21pm, Monday, 05'th Sep 2022
Should investors be watching these dividend paying stocks this week?
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
01:22pm, Monday, 05'th Sep 2022 Zacks Investment Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of inco
Is This Blue Chip Dividend Stock a Buy?
12:00pm, Monday, 05'th Sep 2022 The Motley Fool
Amgen's stock has held up much better than the S&P 500 index.
Is This Blue Chip Dividend Stock a Buy?
08:00am, Monday, 05'th Sep 2022
Amgen's stock has held up much better than the S&P 500 index.
AMGEN ANNOUNCES WEBCAST OF 2022 WELLS FARGO HEALTHCARE CONFERENCE
04:05pm, Friday, 02'nd Sep 2022
THOUSAND OAKS, Calif. , Sept. 2, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Wells Fargo's 2022 Global Healthcare Conference at 9:45 a.m.
AMGEN ANNOUNCES WEBCAST OF 2022 CITI GLOBAL HEALTHCARE CONFERENCE
04:00pm, Friday, 02'nd Sep 2022
THOUSAND OAKS, Calif. , Sept. 2, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2022 Global Healthcare Conference at 8:50 a.m.
Amgen's (AMGN) Lumakras Meets Goal in New Lung Cancer Study
04:12pm, Wednesday, 31'st Aug 2022 Zacks Investment Research
Amgen's (AMGN) phase III CodeBreaK 200 study evaluating once-daily oral, Lumakras, for treating KRAS G12C-mutated non-small cell lung cancer meets its primary endpoint.
Aerie (AERI) Rallies 205.6% in the Past Three Months: Here's Why
03:32pm, Wednesday, 31'st Aug 2022 Zacks Investment Research
Aerie (AERI) shares have skyrocketed in the past three months after the company announced its definitive agreement with Alcon, wherein the latter will acquire the former for $770 million.
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5
03:26pm, Wednesday, 31'st Aug 2022
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
What This News Might Mean for Amgen
01:53pm, Wednesday, 31'st Aug 2022 The Motley Fool
The company finds some protection against measures aimed to cut industry drug prices.
Amgen's (AMGN) Lumakras Meets Goal in New Lung Cancer Study
01:33pm, Wednesday, 31'st Aug 2022
Amgen's (AMGN) phase III CodeBreaK 200 study evaluating once-daily oral, Lumakras, for treating KRAS G12C-mutated non-small cell lung cancer meets its primary endpoint.
Why Amgen's Cancer Drug Results Gave This Small Cap A Big Boost
12:04pm, Wednesday, 31'st Aug 2022
Amgen stock jumped Wednesday after outperforming expectations in a lung-cancer study. It brought rival Mirati along for the ride.
What This News Might Mean for Amgen
09:53am, Wednesday, 31'st Aug 2022
The company finds some protection against measures aimed to cut industry drug prices.
